University of Michigan’s Mints vehicle joined existing investor Intel Capital for SOC producer Movellus’ series A round, which increased the company's overall funding to $10m.

Stanford-founded AI application platform developer SambaNova has raised $150m in a series B round led by Intel Capital that also featured existing investor GV.

NextGen Jane, which is looking to commercialise reproductive health technology partially developed at Harvard, has received $9m from investors including Harvard-affiliated backers.

The customer data technology provider has secured funding in a series D round co-led by existing backer GV at a $1.5bn valuation.

Varian led a round for the targeted cancer drug developer that included fellow existing investors including Johnson & Johnson and Pivotal BioVenture Partners.

Sofinnova Investments added $12m to a series B round backed by PureTech Health and Pivotal BioVenture Partners that has now closed at $80m.

The digital prescription platform's series A round included McKesson Ventures, Novartis, Philips, ResMed, Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin.

University of Michigan critical care monitoring technology spinout Fifth Eye has collected series A funding from investors including the university's Mints fund.

Corporate-backed communication and collaboration platform Slack is targeting the summer for a direct listing on NYSE that will enable Comcast, SoftBank and Alphabet to exit.

Pfizer spinoff Springworks has followed up its $103m series A round two years back by adding $125m in a round that also included GlaxoSmithKline.